FDA approves breakthrough pancreatic cancer treatment

The drug, called daraxonrasib, will be sold under the brand name Rasonque from Revolution Medicines. The daily pill targets multiple forms of a protein called RAS, a main driver of tumor growth.

August 26, 2026